BC Cancer, Vancouver, BC V5Z 1L3, Canada.
Int J Mol Sci. 2022 Oct 14;23(20):12263. doi: 10.3390/ijms232012263.
Therapeutic cancer vaccines have become firmly established as a reliable and proficient form of tumor immunotherapy. They represent a promising approach for substantial advancements in the successful treatment of malignant diseases. One attractive vaccine strategy is using, as the vaccine material, the whole tumor cells treated ex vivo by rapid tumor ablation therapies that instigate stress signaling responses culminating in immunogenic cell death (ICD). One such treatment is photodynamic therapy (PDT). The underlying mechanisms and critical elements responsible for the potency of these vaccines are discussed in this review. Radiotherapy has emerged as a suitable component for the combined therapy protocols with the vaccines. Arguments and prospects for optimizing tumor control using a radiovaccination strategy involving X-ray irradiation plus PDT vaccines are presented, together with the findings supporting its validity.
治疗性癌症疫苗已被牢固确立为一种可靠且高效的肿瘤免疫疗法形式。它们代表了在成功治疗恶性疾病方面取得重大进展的有前途的方法。一种有吸引力的疫苗策略是使用作为疫苗材料的整个肿瘤细胞,这些细胞经过快速肿瘤消融治疗在体外处理,引发应激信号反应,最终导致免疫原性细胞死亡(ICD)。一种这样的治疗方法是光动力疗法(PDT)。本综述讨论了这些疫苗的效力的潜在机制和关键因素。放射疗法已成为与疫苗联合治疗方案的合适组成部分。提出了使用涉及 X 射线照射加 PDT 疫苗的放射疫苗接种策略来优化肿瘤控制的论点和前景,并提供了支持其有效性的发现。